Annelie Falkevall and her co-workers showed that modulating the signalling pathway that controls lipid accumulation in the kidneys might be a possible strategy to treat diabetic kidney disease. Quantification of specific lipids by lipidomics analyses done at the Swedish Metabolomics Centre supported their studies.   

See the article here:

Falkevall et al., Reducing VEGF-B Signaling Ameliorates Renal Lipotoxicity and Protects against Diabetic Kidney Disease, Cell Metabolism, Volume 25, Issue 3, 7 March 2017, Pages 713-726, ISSN 1550-4131
https://doi.org/10.1016/j.cmet.2017.01.004